Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sarepta
Pharma
Sarepta, Roche halt 3 trials in Europe of gene therapy Elevidys
After the death of a patient in the U.S., Sarepta and Roche have temporarily halted three clinical trials in Europe of their gene therapy Elevidys.
Kevin Dunleavy
Apr 3, 2025 11:06am
OIG says FDA accelerated approval program needs adjustments
Jan 16, 2025 3:45pm
Sanofi sues Sarepta over 2 gene therapy manufacturing patents
Jul 30, 2024 5:21pm
FDA broadens label for Sarepta's Duchenne gene therapy Elevidys
Jun 21, 2024 7:51am
Evidence pushes back on FDA's use of surrogate markers: report
May 29, 2024 11:25am
NS Pharma's Duchenne drug Viltepso flunks confirmatory trial
May 28, 2024 11:54am
